검색어: hbsag (영어 - 몰타어)

hbsag lossb
telf hbsagb

hbsag sero- conversion
serokonverżj oni ta’ hbsag

all 57 patients remained positive for hbsag.
is-57 pazjenti kollha baqgħu pożittivi għal hbsag.

- in infants born to hbsag positive mothers.
- fi trabi mwielda minn ommijiet hbsag- pożittivi.

patients should be hbsag negative before treatment start.
il-pazjenti għandhom ikunu negattivi għal hbsag qabel il-bidu tal-kura.

hepatitis b virus surface antigen, recombinant (hbsag) * ...................
antiġen rikombinanti tal-wiċċ tal-virus tal-epatite b (hbsag) * .........

no patients became hbsag- or hbeag-negative during the study.
Ħadd mill-pazjenti ma sar hbsag jew hbeag negattiv matul l-istudju.

this hbsag expressed in yeast cells is purified by several physico-chemical steps.
l-hbsag li toħroġ miċ-ċelluli tal-ħmira tiġi ppurifikata b’diversi stadji fiżiko-kimiċi.

fendrix induces specific humoral antibodies against hbsag (anti-hbs antibodies).
fendrix tinduċi antikorpi speċifiċi ta’ l-umuri kontra l-hbsag (antikorpi kontra l-hbs).

five patients achieved and maintained hbsag seroconversion (hbsag negative/hbsab positive).
Ħamsa pazjenti laħqu u żammew serokonverżjoni ta’ l-hbsag (hbsag negattiv/hbsab pożittiv).

all patients should be screened for hbv infection by measuring hbsag and anti-hbc before initiation of arzerra treatment.
il-pazjenti kollha għandhom jiġu skrinjati għall-infezzjoni b’hbv billi l-hbsag u l-anti-hbc jitkejlu qabel ma tinbeda l-kura b’arzerra.

if your child has fever (vaccination should be delayed). in infants born to hbsag positive mothers.
jekk it-tifel/tifla tiegħek ikollu/ikollha d-deni (it-tilqim għandu jiġi pospost). fi trabi mwielda minn ommijiet hbsag-pożittivi.

the vaccine induces specific humoral antibodies against hepatitis b virus surface antigen (anti-hbsag).
it-tilqima tinduċi antikorpi speċifiċi umorali kontra l-antiġen tal-wiċċ tal-virus tal-epatite b (anti- hbsag).

five subjects randomised to emtricitabine plus tenofovir disoproxil fumarate experienced hbsag loss, with 2 of these 5 subjects experiencing seroconversion to anti-hbs.
Ħames individwi li ġew randomised biex jirċievu emtricitabine flimkien ma’ tenofovir disoproxil fumarate kellhom telf ta’ hbsag, bi 2 minn dawn il-5 individwi esperjenzaw serkonverżjoni għal anti-hbs.

at a minimum this should include hepatitis b surface antigen (hbsag) status and hepatitis b core antibody (hbcab) status.
bħala minimu dan għandu jinkludi l-istat tal-antiġen tas- superfiċje tal-epatite b ( hbsag - hepatitis b surface antigen) u l-istat tal-antikorp tal-qalba tal-epatite b (hbcab - hepatitis b core antibody).

table 4: confirmatory/supplementary assays for anti-hiv 1 and 2, anti-htlv i and ii, anti-hcv, hbsag
tabella 4: analiżi ta' konferma/supplementari għal anti-hiv 1 u 2, anti-htlv i u ii, anti-hcv, hbsag

all 61 patients had hbsag loss post-transplantation, and 2 of these later became hbsag positive despite maintaining undetectable hbv dna (<6 iu/ml).
il-61 pazjenti kollha ma kellhomx hbsag wara t-trapjant, u 2 minn dawn tal-aħħar saru hbsag pożittivi minkejja l-fatt li żammew hbv dna (<6 iu/ml) li ma dehritx.